JAK Inhibitors in Colchicine Resistant FMF Patients: A Case-Based Review
Farhad Salehzadeh, Rasol Molatefi, Faeze Babazadeh Khoei · 2026
Read JAK Inhibitors in Colchicine Resistant FMF Patients: A Case-Based Review by Farhad Salehzadeh, Rasol Molatefi, Faeze Babazadeh Khoei (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13583211.txt.
Description
Farhad Salehzadeh, Rasol Molatefi, and Faeze Babazadeh Khoei review three cases where a JAK inhibitor calmed stubborn familial Mediterranean fever, in a 2026 paper. The fever disorder usually answers to colchicine, but a small share of patients resist it or cannot take it. Biologic drugs work yet cost much and are hard to get in many places.
Three adults who had only partly answered to colchicine plus dapsone took the oral drug twice a day. Over nine to twelve months none had a single attack, and no infection, blood, clotting, or liver harm appeared. The authors back wider study of this oral route as a stand in for costly biologics.
Catalog record
| CREATOR | Farhad Salehzadeh, Rasol Molatefi, Faeze Babazadeh Khoei |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |